Below are the most recent publications written about "Breast Neoplasms" by people in Profiles.
-
Si Y, Peng W, Liu L, Tan M, Wang S, Zheng C, Peng P, Xia Q, Zheng K, Liu X, Liu Y, Tan Y. Brevilin A induces mitochondrial dysfunction and endoplasmic reticulum stress in breast cancer through WWP2-mediated KLF5 degradation. Chin J Nat Med. 2026 Nov; 24(11):1379-1391.
-
Fritz AJ, Greenyer H, Dillac L, Chavarkar P, Neeli A, Ullah R, Malik M, Hong D, Toor R, Pacht E, Person AG, Zotkin G, Korzec S, Gao C, Abuorquob A, Warren J, Del Porto J, Perelman J, Montecino M, Lian JB, Van Wijnen A, Heath J, Ghule P, Frietze S, Zaidi SK, Stengel K, Hiebert S, Reed K, Misteli T, Gordon JA, Stein JL, Stein GS. Acute degron-mediated RUNX1 loss reprograms enhancer activity associated with epithelial destabilization and initiation of cancer hallmarks. Cell Rep. 2026 Oct 27; 45(10):118101.
-
Liu NM, Woods AL, Carney BW, Jiang Y, Abidi HH, Graves CE, Campbell MJ. Adrenal Tumors Identified on Abdominal Imaging in Breast Cancer Patients: Benign Incidentalomas or Metastatic Disease? J Surg Res. 2026 Nov; 327:216-221.
-
Lero MW, Morgan JS, Card MA, Zhu LJ, Li J, Li R, Bui QT, Mohlmann E, Goel HL, Shaw LM. Insulin receptor substrate 2 (IRS2) confers resistance to PI3K pathway inhibition in PIK3CA mutant breast cancer. J Biol Chem. 2026 Oct; 302(10):113426.
-
Yang L, Raza F, Song J, Xi X, Yang S, Xiao H, Jiang L, Chen W, Zhong J, Qiu M, Su J. Copper arsenite-loaded hydrogel for breast cancer therapy via cuproptosis-induced immunity synergized with arsenic chemotherapy. Colloids Surf B Biointerfaces. 2026 Dec; 268(Pt 1):116023.
-
Alabi A, Boateng F, Swanson W, Sowunmi A, Adegboyega B, Ainsworth V, Lawal A, Oshikanlu B, Oyekan A, Ariyo I, Balogun O, Fouad E, Chipidza F, Ngwa W. Radiation therapy in breast cancer patients in south west Nigeria: an evaluation of protocols in a specialist cancer centre. BMC Cancer. 2026 Jul 10; 26(1).
-
Nasrin S, Oulhote Y, Grandjean P, Nielsen F, Hadro J, Lombardo A, Reeves KW. Serum perfluoroalkyl substances (PFASs) concentrations and associations with mammographic density in postmenopausal women. Breast Cancer Res. 2026 07 07; 28(1).
-
Obeidat O, Daise M, Alqudah Q, Tarawneh M, Al-Ani H, Alhuneafat L, Obeidat A, Ismail MF, Obeidat A, Abughazaleh S, Obeidat M, Al-Nusair J, Tong A. Breast cancer and coronary artery disease: insights from a national inpatient sample analysis. Future Cardiol. 2026 Jul; 22(7):717-725.
-
Yuan Y, Lu Y, Han X, Zhang Y, Guo Q, Yao H, Yu Q, Zhou M, Huang X, Wang H, Niu M, Yin J, Rong H, Huang L, Li X, Xu S, Zheng L. ISGylation-mediated stabilization of CYP4Z1 fuels breast cancer initiation and progression. Exp Mol Med. 2026 Jul; 58(7):2202-2222.
-
Park YM, Jung W, Kim BS, Lee M, Fradley MG, Malapati SJ, Naqvi TZ, Henry-Tillman RS, Mehta JL, Han K, Shin DW. Time-Dependent Association Between Breast Cancer and Risk of Ischemic Stroke: A Nationwide Cohort Study. Neurology. 2026 Jul 14; 107(1):e218165.